000 | 01238 a2200337 4500 | ||
---|---|---|---|
005 | 20250515050206.0 | ||
264 | 0 | _c20070124 | |
008 | 200701s 0 0 eng d | ||
022 | _a0278-0240 | ||
024 | 7 |
_a10.1155/2006/670439 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aO'Connor, Kevin C | |
245 | 0 | 0 |
_aComprehensive phenotyping in multiple sclerosis: discovery based proteomics and the current understanding of putative biomarkers. _h[electronic resource] |
260 |
_bDisease markers _c2006 |
||
300 |
_a213-25 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aAutoantibodies _xblood |
650 | 0 | 4 | _aBiomarkers |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aInflammation _xdiagnosis |
650 | 0 | 4 |
_aMultiple Sclerosis _xcerebrospinal fluid |
650 | 0 | 4 |
_aNeurodegenerative Diseases _xdiagnosis |
650 | 0 | 4 | _aPhenotype |
650 | 0 | 4 | _aProteomics |
700 | 1 | _aRoy, Sushmita Mimi | |
700 | 1 | _aBecker, Christopher H | |
700 | 1 | _aHafler, David A | |
700 | 1 | _aKantor, Aaron B | |
773 | 0 |
_tDisease markers _gvol. 22 _gno. 4 _gp. 213-25 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1155/2006/670439 _zAvailable from publisher's website |
999 |
_c16695570 _d16695570 |